I'd like to send this letter by grifulvin v price In August, Amgen Inc agreed to buy OnyxPharmaceuticals Inc for $10.4 billion, thefifth-largest biotechnology deal in history. (Reporting by Zeba Siddiqui in Bangalore and Jessica Toonkel inNew York; Editing by Steve Orlofsky)